SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Dem " 15,817 found 🔀 AI-powered Shuffle
France's Ousmane Dembélé records second-fastest hat trick in World Cup history in 4-1 win over Norway
See inside Kemba Walker's new youth sports hub
The former Charlotte Hornets star says the academy is about creating opportunities for the next generation of athletes.
UC San Diego hosts free Comic-Con events, intersecting health and science through fiction
UC San Diego is holding a badge-free series of comic and science-inspired events in tandem through The Science of Story, from July 21-26.
Deb Haaland Outlines Small Business Agenda in Address to Albuquerque Chamber
Native Vote 2026 Democratic gubernatorial nominee Deb Haaland (Laguna Pueblo) on Thursday outlined her vision for making New Mexico more welcoming to entrepreneurs and small businesses during an address to the Greater Albuquerque Chamber of Commerce, pledging to reduce regulatory barriers while investing in education, public safety, and economic development. Drawing on her own experience […]
Deb Haaland Outlines Small Business Agenda in Address to Albuquerque Chamber
Native Vote 2026 Democratic gubernatorial nominee Deb Haaland (Laguna Pueblo) on Thursday outlined her vision for making New Mexico more welcoming to entrepreneurs and small businesses during an addre...
We have an epidemic of political violence in this country: National Review columnist
National Review columnist Caroline Downey discusses growing political violence and criticizes Illinois Gov. J.B. Pritzker for his remarks about the Chicago cross-burning incident.
We have an epidemic of political violence in this country: National Review columnist
National Review columnist Caroline Downey discusses growing political violence and criticizes Illinois Gov. J.B. Pritzker for his remarks about the Chicago cross-burning incident.
New Nancy Guthrie demand letter claims to have video from her 'last' day: Report
A new demand letter about Nancy Guthrie reportedly claims to have video of the 84-year-old and her kidnapper on 'the day that was probably her last.'
Meet Lara Pires, Valedictorian at Community Academy of Science and Health
Meet Lara Pires, Valedictorian at Community Academy of Science and Health
‘If you’re running in a Democratic primary, you ought to be a Democrat’: Sen. Coons reacts to NYC primary results
Kylie Jenner's former chef alleges 'intense' workload led to miscarriage
Kylie Jenner has been hit with a third workplace lawsuit as her former chef claims the job's "intense" demands led to a pregnancy loss.
New iPhone 18 specs report raises big question of iOS 27 limitations
Apple’s base model iPhone 18 might not get as much RAM as expected—raising questions about support for iOS 27’s most demanding features.
Friday Morning Politics: As Goes New York...?
Lisa Kashinsky talks about the national implications of New York's Democratic primary results.
Texas A&M horticultural sciences students, faculty earn national recognition
Students and faculty within the Texas A&M Department of Horticultural Sciences received national awards for research, outreach and academics.
SGMC Health Honors White with BEE Award
SGMC Health recognized Jessica White, patient care technician on 4 South, as the June recipient of the Being Extraordinary Everyday (BEE) Award, which honors non-nursing staff who demonstrate exceptional compassion, collaboration, and dedication to patient care.
The 5 Healthiest Fats You Can Eat
Fat has historically been demonized, but some types can be good for you.
Texas Democrats meet for convention amid questions about party unity
Democrats see state Rep. James Talarico, D-Austin, as the best opportunity to flip the long-held Republican U.S. Senate seat and want to see how he will win over Black voters.
Democrats call on Mills administration to settle pay dispute
The MSEA is seeking a 2.5% wage increase in the first year, with a $1,250 signing bonus. For year two, the union wants a 3% increase.
Six Watauga students graduate from N.C. School of Science & Mathematics
MORGANTON/DURHAM — Six students from Watauga County were part of 470 from all across North Carolina who graduated this year as members of the residential Class of 2026 of the
Business Owners Agree: The Road to Downtown Recovery Runs Through Facts, Not Nostalgia
State Street's commercial vacancy rate is lower today than it was before the pandemic. The highest vacancy rates remain on blocks that are open to vehicle traffic.
What New York’s primary upheaval means for Democrats: Join Friday’s Whole Hog
Democrats are still feeling the political aftershocks of New York’s primaries on Tuesday night, including New York City Mayor Zohran Mamdani-backed victories. What could it signal for the party? Pl…
Sweden and WHO launch new long-term initiative to transform Ukraine’s health system
WHO and the Swedish International Development Cooperation Agency (Sida) have launched a new multi-year cooperation project to support the long-term recovery and transformation of Ukraine’s health system. The new project, “Ukraine’s Health System Transformation Initiative: Strengthening Health Governance, Health Financing and Service Delivery for Long-Term Recovery”, was launched at the Ukraine Recovery Conference 2026 in Gdansk, Poland on 26 June, and will run from June 2026 to 2029. Sweden will contribute approximately US$ 26 million (240 million Swedish krona) to support this project. This contribution forms part of Sweden’s broader support to Ukraine through the Team Europe approach, which brings together the European Union, its Member States, and key partners such as the European Commission’s Directorate-General for Enlargement and Eastern Neighbourhood and Enabel, and WHO as lead health agency, to support Ukraine’s recovery, reform agenda and European integration.“Ukraine’s health recovery cannot be measured only by what is rebuilt, but by whether people can count on the health system when they need it most. The scale of the task is immense, with health reconstruction and modernization needs estimated at US$ 19.4 billion over the next decade. Sweden’s US$ 26 million contribution to Ukraine’s Health System Transformation Initiative is a timely investment in the institutions, financing and services that will support Ukraine’s long-term recovery and European integration. WHO remains a trusted partner of the Government of Ukraine in advancing this process. I am deeply grateful to Sweden for its consistent support and partnership,” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. More than 4 years of war have placed unprecedented pressure on Ukraine’s health system, creating 3 interconnected challenges. The first is responding to the immediate consequences of the war and the urgent health needs of the population. The second is recovering and modernizing health services today. The third is continuing reforms and aligning the health system with European standards in the context of Ukraine’s future accession to the European Union. The war has led to large-scale population displacement, an increasing need for trauma care and rehabilitation, and shortages of health workers. High out-of-pocket payments in Ukraine make access to health services more difficult. Around 46% of total health expenditure is paid directly by individuals, placing a significant financial burden on many households and underscoring the need for reforms in health financing. Older people, persons with disabilities, women, children and veterans continue to face the greatest difficulties in accessing health services. “Ukraine is demonstrating that health system transformation can continue even during war. Ukraine is also continuing to align its health system with European norms and standards. WHO is committed to supporting Ukraine on this journey. We provide technical support, help coordinate partners’ efforts and support the institutional changes needed to strengthen the system. We are grateful to Sweden for its support. Through this partnership, we can help Ukraine build a more resilient, accessible and people-centred health system,” said Dr Jarno Habicht, WHO Representative in Ukraine. About the Health System Transformation InitiativeThe new initiative will support Ukraine through 3 interconnected areas: strengthening governance and coordination of health sector reforms through more inclusive coordination platforms and structured policy dialogue; transforming service delivery by reinforcing a primary health care-centred model that integrates family medicine, nursing and midwifery; and improving financial sustainability by supporting reforms that ensure the long-term viability of the national health system and reduce out-of-pocket payments for households. Overall, these reforms are expected to make the health system more coherent and easier to navigate, improve the quality and continuity of care, and ensure more equitable access to services, particularly for those who need them most. They will also support Ukraine’s progress towards a more modern health system aligned with European standards. “We are convinced that long-term recovery is not possible without strong, high-quality, person-centred health services that are accessible to everyone. Our partnership with WHO is designed to support deep and lasting systemic changes. Investments in human capital especially autonomous midwives, whose role for maternal, newborn and adolescent sexual and reproductive health cannot be understated, stronger governance, digital transformation and the financial sustainability of the health system are investments in Ukraine’s future. We are proud to support this process,” said Malin Perhult, the Head of the Ukraine Unit at Sida. Focus throughout implementation will be given to the most vulnerable population groups, including older people, women and children, and persons with disabilities, who have been affected by the war and face greater health-care needs. The initiative will be implemented in close cooperation with the Ministry of Health of Ukraine, the National Health Service of Ukraine, the Public Health Centre of Ukraine, regional authorities and international partners. This project will help Ukraine move towards a system where everyone can access the health care they need. It will strengthen primary care, make the health finance system more stable and predictable, and reduce the out-of-pocket costs that Ukrainians face when using health services. As a result, the Ukrainian health system will become more aligned with European standards and more sustainable in the long run.
Supreme Court rules in weedkiller cancer case
Dems want to unmask Eli Lilly's obesity drug user, a new genome-editing tool raises ethics questions, and more health news
KXNO layoffs leave Iowa sports community too quiet
This week's layoffs of local sports radio talkers leaves our sports community worse off, columnist Travis Hines writes.
NC Democrats demand lower utility costs + budget talks drag on as deadline nears
Read our Under the Dome newsletter and listen to our Under the Dome podcast to stay up to date on #ncpol.
Democrats’ real plan to control Congress again
New York’s socialist insurgents are getting the headlines. But in swing House districts, the establishment has been getting its way.
Grand Theft Auto 6 demand may be so high it will "likely outstrip supply" this holiday season, a video game retailer warns
Speaking to The Game Business, a major senior games buyer has warned that stocks might not survive the spending frenzy this fall.
This Democratic congresswoman almost helped elect a Republican speaker
Rep. Marcy Kaptur (D-Ohio) explains why she contemplated supporting Rep. Kevin McCarthy (R-California) in 2023 with an extremely rare crossover vote.
Remembering Victory Stadium: How Roanoke’s lost landmark changed sports and civil rights
It’s been 20 years since Victory Stadium was demolished, but the memories and legacy remain alive in Roanoke.
Reasoning For Pitching Prospect's Absence From Rehab Assignment Revealed
Left-handed pitcher Ricky Tiedemann didn't make an appearance in his rehab assignment in Single-A due a separate injury than the one he's recovering from.
Slotkin says Democratic Party needs 'new leadership': 'Old models are no longer working'
Sen Elissa Slotkin calls for new Democratic Party leadership, saying old models no longer work and the party must simplify its message to win back voters.
California’s Billionaire Tax Kicks Off a Democratic Civil War
The divisive proposal heads to the ballot after attempts to reach a compromise deal failed.
How to manage public investment in science with balance
Public debt is higher today and growing at a faster rate than before the pandemic in 80% of the world's economies. According to the latest fiscal report from the International Monetary Fund, global public ...
New district leaders could take over Brooklyn Democratic Party
The current chair said she believes in "moving forward."
Dems put on blast over poll that shows record-low patriotism in US: 'Tear our society apart'
Rep. Harriet Hageman raises alarm over Gallup poll showing just 17% of Americans were "very proud" of their country, a record low in 25 years.
Senators demand probe into reports of secret Trump-Emrati crypto deal: ‘let them say it under oath’
Blue state leaders erupt after Supreme Court’s decision ending TPS protections for Haitians, Syrians
Supreme Court rules 6-3 in favor of Trump administration in two key immigration cases on Temporary Protected Status and asylum, drawing opposition from blue state Democrats.
Dolly Parton makes surprise appearance — complete with a joke
Dolly Parton just made a surprise appearance, complete with her trademark humor, amid health issues.
Sephora CEO Guillaume Motte on Creating Demand and Scaling Desire
The beauty retailer’s chief executive spoke at day two of The Business of Beauty Global Forum about the strategies that have led to $5 billion in growth over the past three years.
WATCH: House Democratic leaders hold hearing on fair elections and voting rights
House Minority Leader Hakeem Jeffries and Democratic lawmakers held a hearing Thursday on defending fair elections and voting rights.
UT Health San Antonio researcher receives $400,000 Komen grant to study therapeutic yoga for breast cancer survivors
Amelie G. Ramirez, DrPH, MPH, to work with Hispanics in South Texas Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Cliff Despres SAN ANTONIO, June 25, 2026 – Amelie G. Ramirez, DrPH, MPH, a cancer researcher at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, is […]
FlashPoint: How a Christian political media network became a platform for Indiana’s Lt. Gov.
By Sydney Byerly The Indiana Citizen June 25, 2026 When Indiana Lt. Gov. Micah Beckwith called Islam a “demonic death cult” during an appearance on the Christian political program FlashPoint in May, the remarks drew swift backlash from faith leaders across Indiana. It also highlighted the growing influence of the Christian media network that amplified
Democratic socialists’ battleground test: From the Politics Desk
Plus, Pete Buttigieg is back on the campaign trail. And digging into Michael Whatley’s bio in the North Carolina Senate race.
WATCH: Kellyanne Conway insists socialist primary victories don't reflect American values nationwide
Kellyanne Conway says Democratic primary wins reflect only a handful of specific districts and do not signal a broader political shift nationwide.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
How open are Americans to socialism, after all?
Democratic socialists might be having their best year ever.
After wins by democratic socialists, centrist Democrats unite to push back
Thirteen Democratic House members and candidates announced their support for an initiative that commits them to centrist principles.
The Politics Hour: The big winners in MD's primary elections
Leading Democratic nominee for Montgomery County Executive Will Jawando talks about his message to voters, dark money, and data centers. Plus, Tara Jackson wins the Democratic nomination for Prince George's County State's Attorney and WAMU's Alex Koma on D.C. lawmakers greenlighting the budget.
Senate Democrats announce election observer program
The program will put trained, official observers on the ground to observe activities around polling places
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Finding Strength Through Sports While Living with Phenylketonuria
Episode 3 explores how teens with PKU balance the demands and realities of athletics while managing this metabolic condition.
http://democrats-energycommerce.house.gov/media/press-releases/pallone-opening-remarks-health-subcommittee-markup-15-bills
Energy and Commerce Committee Ranking Member Frank Pallone, Jr. (D-NJ) delivered the following opening remarks today at a Health Subcommittee markup of 15 bills:
Misericordia University Students Earn Top Honors at Pennsylvania Academy of Science's 101st Annual Meeting
Misericordia University students earned multiple prestigious awards while showcasing undergraduate research at the 101st Annual Meeting of the Pennsylvania Academy of Science (PAS), held this year on the Misericordia University campus—the first time the statewide scientific organization has hosted its annual conference at the university.
Graham Platner backs legal maneuver using Maine law to rein in political spending
Democratic U.S. Senate nominee Graham Platner wants to overturn the landmark U.S. Supreme Court ruling that enabled corporations and other outside groups to spend unlimited money on elections by any means possible. He supports a constitutional amendment and ethics rules on the high court, which the Sullivan oyster farmer included in his latest policy rollout […]
Two NC lawmakers, a Democrat and a Republican, push Congress to delay SNAP changes
Above the federal penalty threshold, NC could owe $140M a year, putting at risk a program that helps over 1.2 million North Carolinians.
EARLY CHILDHOOD EDUCATION ENDOWMENT ADVISORY BOARD APPROVES HEALTH INSURANCE SUBISIDY PROGRAM FOR EARLY CHILDHOOD EDUCATORS
EARLY CHILDHOOD EDUCATION ENDOWMENT ADVISORY BOARD APPROVES HEALTH INSURANCE SUBSIDY PROGRAM FOR EARLY CHILDHOOD EDUCATORS FOR IMMEDIATE RELEASE June 25, 2026 The Early Childhood Education Endowment’s Advisory Board voted on Tuesday to approve the new early childhood educator health insurance subsidy program beginning in 2027 and available through Access Health CT open enrollment starting October 23, 2026. Established into law…
Trump administration identifies more than 500 migrant children for removal from the US, senator says
The Trump administration has identified more than 500 unaccompanied migrant children in US government custody to be potentially removed from the country, according to Democratic Sen. Ron Wyden.
Cheshire orchard closes after 75 years in business
A longtime Cheshire orchard has announced its closing for good. In a message shared with customers, the family that owns Drazen Orchards said it is now permanently closed and will not reopen for the foreseeable future. The orchard has been open since 1951. The Drazen family said the decision was difficult, citing rising operating costs, the physical demands of running…
Democratic socialists cemented power in New York. Next, the rest of the country?
The wins would not have been possible without significant support from Black and Latino voters who favored them over establishment candidates.
The science of fatherhood from brain changes to ‘dad bod’
Darby Saxbe’s book combines academic data with ‘stories about the men in her own life’
Six Female Student-Athletes Named to College Sports Communicators At Large Academic All-District Team
Springfield, Mass. – June 23, 2026 – Six Springfield College student-athletes were named to the 2026 College Sports Communicators (CSC) Academic All-District Team this year.
Waterloo's Grout Museum District to demolish its Bluedorn Science Imaginarium amid funding changes
This summer, the Grout Museum District is preparing to demolish its former science center, the Bluedorn Science Imaginarium. The decision was made in the face of funding uncertainty stemming from property tax reform in Waterloo.
Another look at carrots and eyesight; how to get more fiber; why mosquitoes bite some people and not others; plus other stories with Vanderbilt Health sources
AARP reporter Stacey Colino interviewed Milam Brantley, MD, Associate Professor of Ophthalmology and Visual Sciences, in 2020 for a story about whether eating carrots can improve vision. Sacramento Bee reporter Samantha Agate has now used Brantley’s comments in an AI-curated story created by content specialists on the same topic that has been picked up by MSN and others. Prevention magazine interviewed Heidi Silver, RD, PhD, Founding Director of the Vanderbilt Diet, Body Composition, and Human Metabolism Core, for a story about the importance of fiber and how people can get more of it in their diet. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Women’s Health (tick bites and alpha-gal syndrome); The Washington Post (tetanus); and Healthline (why mosquitoes prefer to bite some people and leave others alone). A visit to Monroe Carell Jr. Children’s Hospital at Vanderbilt by some Banana Ball baseball players was covered by The Tennessean and WZTV Fox 17 News, and The Tennessean’s story was also picked up by Yahoo! Sports. Clarksville Now published a story written by the Montgomery County Economic Development Team, whointerviewed Bradley Stancombe, MD, professor of Clinical Pediatrics, Vanderbilt Neonatology, about the new energy of Vanderbilt Clarksville Hospital and how the facility is recruiting physicians. Healio Allergy/Asthma group editorial director Richard Gawel interviewed Mark Rolfsen, MD, Clinical Fellow in the Division of Allergy, Pulmonary and Critical Care Medicine, for a story about his presentation at the American Thoracic Society meeting on metal health outcomes following ICU discharge. Nashville Scene reporter Hannah Herner interviewed James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a story about his efforts to prepare for the next pandemic by isolating antibodies that can neutralize dangerous viruses. Medscape reporter Kathleen Doheny interviewed Neesha Choma, Associate Chief of Staff of Vanderbilt University Hospital, for a story about how hospitals can reduce readmissions.
CMS projects national health spending grew to $5.7 trillion in 2025
National health spending is projected to have reached $5.7 trillion in 2025, up 7.3% from 2024, according to an analysis by the Centers for Medicare & Medicaid Services published yesterday by Health Affairs. It marks the third consecutive year of growth greater than 7%. CMS projects growth to continue in 2026 due to continued demand for high-cost retail prescription drugs, mostly from individuals with Medicare and private insurance.
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
First-of-its-kind discovery earns UT Health San Antonio Mays Cancer Center fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
Here’s What It Means to Be a Democratic Socialist
Universal health care, taxing the wealthy and opposition to military aid to Israel are among the movement’s key tenets.
Texas Democrats head to convention with optimism, but questions about November remain
The Texas Democratic Convention begins Thursday in Corpus Christi. The three-day convention features several national and statewide figures in the party — this while polls show Democratic candidate James Talarico essentially even with his Republican opponent for U.S. Senate, Attorney General Ken Paxton.
Mamdani on election wins: New Yorkers exhausted with ‘status quo politics’
New York City Mayor Zohran Mamdani (D) said voters showed they were exhausted with “status quo politics” by backing democratic socialists in state and federal primaries on Tuesday. Three Mamdani-ba…
Democratic socialists cemented power in New York. Next, the rest of the country?
The Democratic Socialists of America won with support outside their usual base. Winning outside New York may be a different challenge.
Trump to meet House speaker in attempt to break legislative gridlock
Trump suddenly scrapped the signing of a pivotal bipartisan housing bill yesterday, demanding the Senate pass his voter ID bill
Suspect in $5,000 Academy Sports theft arrested
MEMPHIS, Tenn. — A man accused of stealing over $5000 worth of merchandise from Academy Sports and Outdoor over a span of two days earlier this month is now in jail. Carltrell Taylor, 39, is …
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Democracy’s Defenses, Democracy’s Undoing
A broad range of views on democracy to help break the stalemate caused by partisan conflict.
BBC and Sidemen to host World Cup watchalong
BBC Sport and YouTube collective the Sidemen team up for a World Cup watchalong on Thursday.
Oakland Athletics Partners with Motion Sports
ROCHESTER, Mich. - Oakland University has announced a new partnership with Motion, the modern technology platform built for college athletic departments. The Golden Grizzlies will implement Motion across their athletic department, giving coaches, academic staff, and student-athletes a cleaner, more connected way to work.
Commentary: Why Archie Bunker voters are disillusioned with U.S. politics
The 1970s “All in the Family” stalwart supported law-and-order, cultural conservatism and strong labor unions, values to which many Republicans have gravitated, while Democrats evolved into a constituency that adopted identity…
How a New York race became the first front in the AI industry’s midterm war
Competing AI interests poured millions into the Democratic primary, a taste of more spending to come this fall and elections beyond.
Mamdani's success in New York tests Democratic Party's willingness to change
New York City Mayor Zohran Mamdani has stepped into the national spotlight this week as a surging political force within the Democratic Party.
Mamdani's success in New York tests Democratic Party's willingness to change
New York City Mayor Zohran Mamdani has stepped into the national spotlight this week as a surging political force within the Democratic Party.
Mamdani's Success in New York Tests Democratic Party's Willingness to Change
NEW YORK (AP) — New York City Mayor Zohran Mamdani stepped into the national spotlight this week as an ascendant political force within the Democratic Party. Democratic leaders aren't so sure that's a good thing. As progressives cheered across the nation, some of the most powerful Democrats in the ...
Closed-door outburst turns into victory for Trump’s Iran negotiations
Senate Republicans flipped to reject Democrats' Iran war powers resolution, handing Trump a key win as U.S.-Iran peace deal talks continue on.
CMS projection: 90% of Americans will still have health insurance in 2034—when healthcare spending reaches $9T
Legislative changes, demographic shifts and growing demand will combine to drive national health spending to almost $9 trillion by 2034.
'Stone Crazy' Millwood business owner entices neighbors outdoors with crystal searches
Nowadays, the sole proprietor of Millwood’s Stone Crazy crystal shop is enticing today’s youth to follow in her outdoorsy footsteps— quite literally. Since the pandemic, Jenny Dykes has been leaving crystals from her business along Inland Northwest trails to spur others into exploring public lands.
Jacob Elordi, Teyana Taylor invited to join Oscars voters
Jacob Elordi, Julia Garner, Simu Liu, Jenna Ortega and Teyana Taylor are among the boldface names invited to join the Academy of Motion Picture Arts and Sciences.
Mamdani's sweep in New York a 'political earthquake' among Democrats
New York City Mayor Zohran Mamdani scored a massive political victory on Tuesday when his trio of insurgent congressional candidates toppled two incumbents and the establishment favorite in an open seat, results some described as "a political earthquake" for Democrats.
Why urban Democrats love socialists now
Democratic socialists are winning in New York — and in other cities. Can they win elsewhere?
A tale of two Democratic parties: From the Politics Desk
Plus, Trump slams the brakes on a bipartisan housing bill.
Kennedy scion Jack Schlossberg loses crowded New York City congressional primary
Kennedy family scion and political novice Jack Schlossberg lost Tuesday to New York state Assembly Member Micah Lasher, in a closely watched and crowded Democratic primary for an open congressional seat in the heart of Manhattan.
A new paper argues Microsoft exaggerated its quantum claims a year ago
A peer-reviewed critique of Majorana 1 claims Microsoft did not conclusively demonstrate a working topological qubit. Microsoft disagrees.
Political earthquake strikes House Democrats and Hispanic caucus with Espaillat's loss
Ex-aides win primaries to replace retiring Democratic House members
U.S. Reps. Steny Hoyer and Jerrold Nadler passed the torch Tuesday night to former aides who won the Democratic primaries to replace them on Capitol Hill.
An emboldened hard left eyes Schumer challenge
The Democratic Senate leader is staring down a tectonic shift in his home state.
Jasmine Crockett’s silence could hurt James Talarico’s U.S. Senate chances in November
The Dallas congresswoman, Talarico’s erstwhile rival in the Democratic primary, has yet to say whether she’ll campaign for him in the general election against Republican Ken Paxton.
White House Melts Down Over Dem’s Attack on Trump’s Health
Steven Cheung hit back with a profane tirade against Rep. Ted Lieu.
Micron forecasts quarterly revenue above estimates
Micron Technology forecast quarterly revenue above Wall Street estimates on Wednesday, signaling that insatiable demand for AI-related infrastructure will continue to drive strong demand for its memory chips.